EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Dr. Vivien Bonazzi Named Chief Data Officer at Inari
Prior to joining Inari, Dr. Vivien Bonazzi served as chief biomedical data scientist and managing director at Deloitte Consulting LLP.
InfuSystem Announces CEO Transition | Carrie Lachance to Become CEO Effective May 19, 2025
“Carrie Lachance has been at the center of InfuSystem’s succession plan for the past several years, and she is the ideal person to succeed Rich DiIorio having spent the last decade plus working her way up through ever greater positions of responsibility within the Company,” said Scott Shuda, Chairman of the board of InfuSystem.
ITM Appoints Dr. Celine Wilke Chief Medical Officer
“Celine brings a wealth of experience in advancing radiopharmaceutical precision oncology treatments from early development through to regulatory approval. As she steps into the leadership of our medical team, her expertise will be instrumental in progressing our pipeline and delivering new treatment options for patients,” said Dr. Andrew Cavey, Chief Executive Officer of ITM.
Nuage Therapeutics Appoints Dr. Stuart Hughes CEO and Vanessa Malier as Chair
Nuage Therapeutics applying its proprietary technology to advance a pipeline of novel agents targeting oncogenic transcription factors.
Olga Uspenskaya-Cadoz Appointed Chief Medical Officer of VectorY Therapeutics
Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.
Operation Warp Speed Leader Tapped as Panther Life Sciences’ New R&D Chief | The Appointment of Dr Matthew Hepburn to Expand Panther’s Leadership For...
In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.
Michael Andersen Joins Vektor Medical as Vice President, Quality Assurance and Regulatory Affairs
Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.
Abbas Kazimi Steps Up as Dynamic CEO of Nimbus Therapeutics
"I am honored to lead Nimbus at this pivotal time in the company's evolution," said Abbas Kazimi. "Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I'm particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”
Mirva Ekman Appointed Quality Director & Member of the Management Team at Bioretec
Mirva Ekman over 20 years of experience in quality and regulatory leadership.
Medical Device News Magazine